Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Tandem Diabetes Care Yönetim
Yönetim kriter kontrolleri 4/4
Tandem Diabetes Care's CEO'su John Sheridan, Apr2013 tarihinde atandı, in görev süresi 11.5 yıldır. in toplam yıllık tazminatı $ 4.65M olup, şirket hissesi ve opsiyonları dahil olmak üzere 15.3% maaş ve 84.7% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.076% ine doğrudan sahiptir ve bu hisseler $ 2.11M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 3.1 yıl ve 4.3 yıldır.
Anahtar bilgiler
John Sheridan
İcra Kurulu Başkanı
US$4.7m
Toplam tazminat
| CEO maaş yüzdesi | 15.3% |
| CEO görev süresi | 11.5yrs |
| CEO sahipliği | 0.08% |
| Yönetim ortalama görev süresi | 3.1yrs |
| Yönetim Kurulu ortalama görev süresi | 4.3yrs |
Son yönetim güncellemeleri
Recent updates
Health Check: How Prudently Does Tandem Diabetes Care (NASDAQ:TNDM) Use Debt?
Sep 28
Potential Upside For Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Not Without Risk
Aug 31Tandem Diabetes: Mobi's Surprise Sales Fail To Offset Flat Operating Margin
Aug 14Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Aug 04Is It Time To Consider Buying Tandem Diabetes Care, Inc. (NASDAQ:TNDM)?
Jul 12Is Tandem Diabetes Care (NASDAQ:TNDM) Weighed On By Its Debt Load?
Jun 18Tandem Diabetes Care: Recent Rally Fully Deserved, Likely More Upside Here
May 29Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM) 26% Jump Shows Its Popularity With Investors
May 10A Look At The Fair Value Of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
May 04At US$30.10, Is Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Worth Looking At Closely?
Mar 26Even With A 27% Surge, Cautious Investors Are Not Rewarding Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM) Performance Completely
Mar 08Is Tandem Diabetes Care (NASDAQ:TNDM) Using Debt In A Risky Way?
Feb 22Estimating The Intrinsic Value Of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
Jan 14Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Stock Rockets 63% But Many Are Still Ignoring The Company
Dec 27Is It Too Late To Consider Buying Tandem Diabetes Care, Inc. (NASDAQ:TNDM)?
Nov 12Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM) Intrinsic Value Is Potentially 53% Above Its Share Price
Oct 06Does Tandem Diabetes Care (NASDAQ:TNDM) Have A Healthy Balance Sheet?
Sep 17Should You Think About Buying Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Now?
Aug 08Calculating The Intrinsic Value Of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
Jul 03Is Tandem Diabetes Care (NASDAQ:TNDM) Using Debt Sensibly?
Jun 13Cautious Investors Not Rewarding Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM) Performance Completely
May 06Is Tandem Diabetes Care (NASDAQ:TNDM) Using Debt In A Risky Way?
Jan 04Is Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Potentially Undervalued?
Oct 15Tandem Diabetes Care: Overpriced, Underdelivering
Sep 22An Intrinsic Calculation For Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Suggests It's 50% Undervalued
Sep 10Tandem Diabetes stock falls 10% on disappointing Q2 result
Aug 03Tandem Diabetes Care acquires Capillary Biomedical; terms undisclosed
Jul 21Tandem Diabetes Care: Strong Financials And Revenue, Overpenalized For Missed Earnings
Jul 08Tandem Diabetes Care (NASDAQ:TNDM) Is Looking To Continue Growing Its Returns On Capital
Jun 20Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM) Intrinsic Value Is Potentially 43% Above Its Share Price
May 30CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$136m |
| Mar 31 2024 | n/a | n/a | -US$141m |
| Dec 31 2023 | US$5m | US$711k | -US$223m |
| Sep 30 2023 | n/a | n/a | -US$208m |
| Jun 30 2023 | n/a | n/a | -US$224m |
| Mar 31 2023 | n/a | n/a | -US$204m |
| Dec 31 2022 | US$6m | US$711k | -US$95m |
| Sep 30 2022 | n/a | n/a | -US$68m |
| Jun 30 2022 | n/a | n/a | -US$13m |
| Mar 31 2022 | n/a | n/a | US$6m |
| Dec 31 2021 | US$6m | US$690k | US$16m |
| Sep 30 2021 | n/a | n/a | US$22m |
| Jun 30 2021 | n/a | n/a | US$7m |
| Mar 31 2021 | n/a | n/a | -US$25m |
| Dec 31 2020 | US$4m | US$600k | -US$34m |
| Sep 30 2020 | n/a | n/a | -US$49m |
| Jun 30 2020 | n/a | n/a | -US$42m |
| Mar 31 2020 | n/a | n/a | -US$17m |
| Dec 31 2019 | US$11m | US$500k | -US$25m |
| Sep 30 2019 | n/a | n/a | -US$24m |
| Jun 30 2019 | n/a | n/a | -US$55m |
| Mar 31 2019 | n/a | n/a | -US$113m |
| Dec 31 2018 | US$2m | US$386k | -US$123m |
| Sep 30 2018 | n/a | n/a | -US$138m |
| Jun 30 2018 | n/a | n/a | -US$119m |
| Mar 31 2018 | n/a | n/a | -US$82m |
| Dec 31 2017 | US$596k | US$375k | -US$73m |
Tazminat ve Piyasa: John 'nin toplam tazminatı ($USD 4.65M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 6.79M ).
Tazminat ve Kazançlar: John 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.
CEO
John Sheridan (69 yo)
11.5yrs
Görev süresi
US$4,651,603
Tazminat
Mr. John F. Sheridan has been President and Chief Executive Officer at Tandem Diabetes Care, Inc., since March 01, 2019 and served as its Chief Operating Officer and Executive Vice President since April 20...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| President | 11.5yrs | US$4.65m | 0.076% $ 2.1m | |
| Executive VP | 6.8yrs | US$1.25m | 0.049% $ 1.3m | |
| Executive VP & Chief Administrative Officer | 11.1yrs | US$1.25m | 0.036% $ 976.4k | |
| Transitional Advisor | less than a year | US$1.25m | 0.011% $ 291.6k | |
| Executive Vice President and Chief Strategy & Product Officer | 3.3yrs | US$1.25m | 0.020% $ 548.4k | |
| Executive VP & Chief Commercial Officer | less than a year | US$2.72m | Veri yok | |
| Executive VP & COO | less than a year | Veri yok | Veri yok | |
| Chief Technical Officer | 2.9yrs | Veri yok | 0.020% $ 535.0k | |
| Executive VP | 2.8yrs | Veri yok | 0.018% $ 485.2k | |
| Chief Human Resources Officer | 7.2yrs | Veri yok | Veri yok | |
| Chief Medical Officer | less than a year | Veri yok | Veri yok | |
| Chief Manufacturing Officer | 7.2yrs | Veri yok | 0.026% $ 705.1k |
3.1yrs
Ortalama Görev Süresi
56yo
Ortalama Yaş
Deneyimli Yönetim: TNDM 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.1 yıldır).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| President | 5.3yrs | US$4.65m | 0.076% $ 2.1m | |
| Independent Chairwoman of the Board | 5.8yrs | US$222.78k | 0.014% $ 392.5k | |
| Chair Emeritus | less than a year | US$198.78k | 0.34% $ 9.3m | |
| Independent Director | 11.3yrs | US$200.95k | 0.037% $ 1.0m | |
| Independent Director | 17.3yrs | US$214.67k | 0.059% $ 1.6m | |
| Independent Director | 4.2yrs | US$190.28k | 0.025% $ 697.2k | |
| Independent Director | 3.8yrs | US$189.25k | 0.017% $ 465.2k | |
| Independent Director | 4.3yrs | US$189.25k | 0.021% $ 562.6k | |
| Independent Director | 2.3yrs | US$176.55k | 0.012% $ 315.9k | |
| Independent Director | 2.3yrs | US$177.55k | 0.012% $ 315.9k |
4.3yrs
Ortalama Görev Süresi
61.5yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: TNDM 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 4.3 yıldır).